Penn expert addresses ethical implications of testing for Alzheimer's disease risk

Early diagnosis without treatment options creates individual, societal conundrum

2012-07-18

(Press-News.org) VANCOUVER – Diagnostic tests are increasingly capable of identifying plaques and tangles present in Alzheimer's disease, yet the disease remains untreatable. Questions remain about how these tests can be used in research studies examining potential interventions to treat and prevent Alzheimer's disease. Experts from the Perelman School of Medicine at the University of Pennsylvania will today participate in a panel at the Alzheimer's Association International Conference 2012 (AAIC 2012) discussing ways to ethically disclose and provide information about test results to asymptomatic older adults.

In contrast to diseases like cancer - where tumor progression and genetic markers can be measured to determine appropriate preventative steps or targeted treatments - Alzheimer's disease tests has improved diagnosis and assessment of risk, but no treatments or preventative measures are available to alter the disease progression.

Previous research has suggested that knowing biomarker results can be harmful to people at increased risk for Alzheimer's disease, potentially causing anxiety or depression.

"It is important to track the impact of revealing biomarker results to asymptomatic individuals, so we can develop and disseminate best practices," notes panelist Jason Karlawish, MD, professor in Geriatric Medicine as well as Medical Ethics and Health Policy in the Perelman School of Medicine at the University of Pennsylvania.

Since an increased risk does not mean someone will definitively get the disease, safeguards are needed to ensure individuals aren't marginalized or mistreated. While having tests available to assess risk can be helpful in diagnosing or ruling out Alzheimer's disease, there is still no consensus on how the test results will be shared with individuals, with insurance companies, and even with employers. And for those with early stages of the disease or mild cognitive impairment, standards on workplace accommodations will need to be implemented.

As researchers look to intervene in the disease as early as possible, prevention trials will need to enroll people who are at high risk for developing AD but are not suffering from symptoms. One planned prevention study will select people found to be at high risk based on amyloid imaging tests, therefore revealing test results to eligible participants. The prevention trial will also include an ethics sub-study, to gauge the emotional impact on patients learning their positive or negative amyloid status.

"This prevention trial is an excellent opportunity to better understand how older adults make sense of biomarker results and how the results impact health and overall well-being," said Karlawish, associate director of the Penn Memory Center. "Methods used for revealing genetic test results provide a template to disclose risk information to asymptomatic individuals."

### Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

The Perelman School of Medicine is currently ranked #2 in U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $479.3 million awarded in the 2011 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top 10 hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital – the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2011, Penn Medicine provided $854 million to benefit our community.

ELSE PRESS RELEASES FROM THIS DATE:

Modified tPA could be effective stroke treatment without bleeding risk

2012-07-18

Even when its clot-dissolving powers are removed, the stroke drug tPA can still protect brain cells from the loss of oxygen and glucose induced by a stroke, researchers have discovered. The finding suggests that a modified version of tPA could provide benefits to patients who have experienced a stroke, without increasing the risk of bleeding. The results will be published in the Journal of Neuroscience. "We may have been giving the right medication, for the wrong reason," says senior author Manuel Yepes, MD, associate professor of neurology at Emory University School ...

Stanford researchers calculate global health impacts of the Fukushima nuclear disaster

2012-07-18

Radiation from Japan's Fukushima Daiichi nuclear disaster may eventually cause anywhere from 15 to 1,300 deaths and from 24 to 2,500 cases of cancer, mostly in Japan, Stanford researchers have calculated. The estimates have large uncertainty ranges, but contrast with previous claims that the radioactive release would likely cause no severe health effects. The numbers are in addition to the roughly 600 deaths caused by the evacuation of the area surrounding the nuclear plant directly after the March 2011 earthquake, tsunami and meltdown. Recent PhD graduate John Ten ...

New way of mapping physicians provides valuable network science tool

2012-07-18

BOSTON – A new way of mapping how physicians share patients provides opportunities for improving the quality of medical care and organizing the nature of care delivery, according to researchers from Beth Israel Deaconess Medical Center and Harvard Medical School. In a study published in the July 18 edition of the Journal of the American Medical Association, researchers suggest this new way of systematically looking at how physicians are organized into patient-sharing networks can shed light on practice variation, aid in the spread of innovation and help form natural groups ...

Access to clinical trials drives dramatic increases in survival from childhood cancer

2012-07-18

More children are surviving cancer in Britain than ever before according to new research published in the cancer journal Annals of Oncology [1] today (Wednesday). The improvement in survival has been driven by the increasing numbers taking part in clinical trials since 1977 when the UK Children's Cancer Study Group (UKCCSG) [2] was established. The UKCCSG's principal aim was to set up a comprehensive portfolio of national and international trials for the majority of children's cancers. As result, between 1978 and 2005 two-thirds of children diagnosed with cancer in Britain ...

20-year quest ends as scientists pin down structure of elusive, heart-protective protein

2012-07-18

It is a cellular component so scarce, some scientists even doubted its existence, and many others gave up searching for its molecular structure. Now a team led by researchers at Johns Hopkins has defined the protein structural composition of mitoKATP, a potassium channel in the mitochondria of the heart and other organs that is known to protect against tissue damage due to a heart attack or stroke. Importantly, the newly found channel strongly improves heart cell survival, demonstrating an essential life-saving role. In a report to be published in the journal Circulation ...

Johns Hopkins researchers link 2 biological risk factors for schizophrenia

2012-07-18

Johns Hopkins researchers say they have discovered a cause-and-effect relationship between two well-established biological risk factors for schizophrenia previously believed to be independent of one another. The findings could eventually lead researchers to develop better drugs to treat the cognitive dysfunction associated with schizophrenia and possibly other mental illnesses. Researchers have long studied the role played in the brain's neurons by the Disrupted-in-Schizophrenia 1 (DISC1) gene, a mutation with one of the strongest links to an increased risk of developing ...

Study may explain how exercise improves heart function in diabetics

2012-07-18

A detailed study of heart muscle function in mice has uncovered evidence to explain why exercise is beneficial for heart function in type 2 diabetes. The research team, led by scientists at the Johns Hopkins University School of Medicine, found that greater amounts of fatty acids used by the heart during stressful conditions like exercise can counteract the detrimental effects of excess glucose and improve the diabetic heart's pumping ability in several ways. The findings also shed light on the complex chain of events that lead to diabetic cardiomyopathy, a form of heart ...

BGI debuts new tool 'PDXomics' for tumor xenograft research and applications

2012-07-18

July 17, 2012, Shenzhen, China – BGI, the world's largest genomics organization, announced today that it has successfully developed a new filtering tool, PDXomics, which performs accurate and specific classification of the mixed reads derived from the host and tumor xenografts. Through the full utilization of this robust tool, researchers could develop the specific patient-derived xenografts (PDX) and advance the oncology drug discovery, biomarker development and their future applications. Xenograft models serve as an important tool for many areas of biomedical research, ...

Beating the fuel prices: Using yeast for economic production of bioethanol

2012-07-18

Finding renewable and economic sources of energy are one of the most important concerns for the continuation of the human species. New research, published in BioMed Central's open access journal Biotechnology for Biofuels, has produced a novel strain of yeast with improved xylose tolerance and metabolism, and consequently improved ethanol production. Bioethanol is considered one of cleanest renewable replacements for fossil fuel. However using glucose from crops, such as sugar cane or starch crops, uses up resources which could otherwise be used to produce food. Xylose ...

Milk thistle, taken by many people for liver disease, ineffective as treatment for hepatitis C

2012-07-18

CHAPEL HILL, N.C. – Silymarin or "milk thistle," a popular herbal dietary supplement that many people take for liver ailments, works no better than placebo in patients with chronic hepatitis C infection. That's the conclusion of a multicenter clinical trial published in the July 18, 2012 issue of the Journal of the American Medical Association. "Patients ask me about milk thistle all the time," said Michael W. Fried, MD, lead author of the study, a professor in the University of North Carolina School of Medicine and director of the UNC Liver Center. "Now I can tell ...

In small preliminary study, fearful pet dogs exhibited significantly different microbiomes and metabolic molecules to non-fearful dogs, suggesting the gut-brain axis might be involved in fear behavior

Examination of Large Language Model "red-teaming" defines it as a non-malicious team-effort activity to seek LLMs' limits and identifies 35 different techniques used to test them

Most microplastics in French bottled and tap water are smaller than 20 µm - fine enough to pass into blood and organs, but below the EU-recommended detection limit

Penn expert addresses ethical implications of testing for Alzheimer's disease risk

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: